Literature DB >> 9189227

Marked hyperlipidaemia on ritonavir therapy.

A K Sullivan, M R Nelson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9189227

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  15 in total

1.  Metabolic Abnormalities Associated with the Use of Protease Inhibitors and Non-nucleoside Reverse Transcriptase Inhibitors.

Authors:  Madhu N Rao; Grace A Lee; Carl Grunfeld
Journal:  Am J Infect Dis       Date:  2006-09-30

2.  Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors.

Authors:  Carl Grunfeld; Donald P Kotler; Donna K Arnett; Julian M Falutz; Steven M Haffner; Paul Hruz; Henry Masur; James B Meigs; Kathleen Mulligan; Peter Reiss; Katherine Samaras
Journal:  Circulation       Date:  2008-06-19       Impact factor: 29.690

Review 3.  Pharmacokinetic Enhancement of HIV Antiretroviral Therapy During Pregnancy.

Authors:  Engie Salama; Ahizechukwu C Eke; Brookie M Best; Mark Mirochnick; Jeremiah D Momper
Journal:  J Clin Pharmacol       Date:  2020-08-14       Impact factor: 3.126

4.  Metabolic effects of indinavir in healthy HIV-seronegative men.

Authors:  M A Noor; J C Lo; K Mulligan; J M Schwarz; R A Halvorsen; M Schambelan; C Grunfeld
Journal:  AIDS       Date:  2001-05-04       Impact factor: 4.177

Review 5.  Drug-Induced lipid changes: a review of the unintended effects of some commonly used drugs on serum lipid levels.

Authors:  A K Mantel-Teeuwisse; J M Kloosterman; A H Maitland-van der Zee; O H Klungel; A J Porsius; A de Boer
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 6.  Lipodystrophy syndrome in HIV infection: what is it, what causes it and how can it be managed?

Authors:  G M Behrens; M Stoll; R E Schmidt
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

Review 7.  Metabolic complications associated with HIV protease inhibitor therapy.

Authors:  David Nolan
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 8.  Metabolic Complications and Glucose Metabolism in HIV Infection: A Review of the Evidence.

Authors:  Amanda L Willig; Edgar Turner Overton
Journal:  Curr HIV/AIDS Rep       Date:  2016-10       Impact factor: 5.071

9.  The association between the receipt of lipid lowering therapy and HIV status among veterans who met NCEP/ATP III criteria for the receipt of lipid lowering medication.

Authors:  Matthew S Freiberg; David A Leaf; Joseph L Goulet; Matthew B Goetz; Krisann K Oursler; Cynthia L Gibert; Maria C Rodriguez-Barradas; Adeel A Butt; Amy C Justice
Journal:  J Gen Intern Med       Date:  2009-01-06       Impact factor: 5.128

Review 10.  [HIV, AIDS and the cardiovascular risk].

Authors:  T Neumann
Journal:  Internist (Berl)       Date:  2008-04       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.